Evidence map›Paper›PMID 42098442›Full record

ArticleOncogene2026

The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.

Yuning Liao, Wenshuang Sun, Yuting Li, Yuanfei Deng, Qing Liu, Shusha Yin, Yujie Xiang, E-Ying Peng, Yu Yao, Wanying He and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yuning Liao *Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China. 2019990003@gzhmu.edu.cn.ORCID http://orcid.org/0009-0003-0767-3937
Wenshuang Sun *Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0000-0003-2692-6648
Yuting Li *Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0009-0001-7333-0372
Yuanfei DengDepartment of Pathology, The First People's Hospital of Foshan, Foshan, China.ORCID http://orcid.org/0000-0002-8326-2713
Qing LiuDepartment of Pathology, The First People's Hospital of Foshan, Foshan, China.ORCID http://orcid.org/0000-0002-4101-3495
Shusha YinGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0009-0002-9780-9027
Yujie XiangGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0009-0003-1441-3164
E-Ying PengGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Yu YaoGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0009-0002-3343-3235
Wanying HeGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Zhenlong ShaoGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.ORCID http://orcid.org/0000-0001-8039-8706
Gengxi CaiDepartment of Breast Surgery, The First People's Hospital of Foshan, Foshan, China.ORCID http://orcid.org/0000-0003-0575-4314
Hongbiao HuangGuangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China. huanghongbiao@gzhmu.edu.cn.ORCID http://orcid.org/0000-0002-9873-0559

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82373327
6 · The paper itself

Abstract

Development of castration resistance and distant metastasis remain two major clinical challenges in prostate cancer (PCa) treatment. By analyzing multiple public cancer datasets, we found that ribosomal protein S15 (RPS15) is overexpressed in PCa and related to its metastasis. Beyond its canonical role as a structural component of the ribosome, emerging evidence has highlighted the extraribosomal functions of RPS15 in disease progression. Our study demonstrates that RPS15 significantly promotes proliferation and migration in PCa through the establishment of RPS15 knockdown cells and xenograft models. Mechanistically, RPS15 interacts with the functional domain of DExD-box helicase 21 (DDX21) and facilitates the binding of DDX21 to the transcription start region of stearoyl-CoA desaturase-1 (SCD1), thereby enhancing its transcriptional activity and protein expression to drive the growth, ferroptosis-resistance, and metastasis of PCa cells. Moreover, analysis of clinical samples revealed that RPS15, DDX21, and SCD1 are concomitantly upregulated and exhibit strong positive correlations in PCa tissues. Collectively, our findings uncover the significance of the RPS15-DDX21-SCD1 axis in PCa development, expanding the understanding of noncanonical functions of ribosomal proteins and providing new insights for PCa management.

Indexed as

DEAD-box RNA HelicasesProstatic NeoplasmsRibosomal ProteinsStearoyl-CoA DesaturaseTranscriptional ActivationAnimalsCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansMaleMiceDDX21 protein, humanDEAD-box RNA HelicasesRibosomal ProteinsSCD protein, humanStearoyl-CoA Desaturase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.